Search

everythinglearnresearchcommunity

for

Search:↓

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

PBX1 helps reduce aging and cell death in hair follicle stem cells by decreasing DNA damage, not by improving DNA repair.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Fibroblast growth factors could be a better, safer treatment for hair loss than current options.

Minoxidil boosts hair growth by activating PGHS-1.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Potassium channel openers help form elastic fibers in arteries and can treat elastin deficiency and hypertension.

ocu-miR-205 affects hair density in Rex rabbits by altering hair follicle growth and signaling pathways.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Cortisol increases a specific protein in bone cells, which may help explain its negative effects on bone.

Finding functions for unknown GPCRs is hard but key for making new drugs.

The estrogen receptor pathway controls hair growth cycles and affects skin cell growth.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

The TRPV3 channel structure changes linked to severe itch and hyperkeratosis were identified using cryo-EM.

PPAR-γ signaling improves mitochondrial function in hair follicles, potentially affecting hair growth and aging.

A gene variation is linked to hair thickness in Asians.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

TRH stimulates human hair growth and extends the hair growth phase.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

The NF-κB effector p65/RelA activates hair keratin genes, aiding hair formation.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.